DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Chang KC, Tseng PL, Wu YY. , et al.
A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
Clin Gastroenterol Hepatol 2015;
13 (05) 1017-1024
We do not assume any responsibility for the contents of the web pages of other providers.